公开(公告)号：US20240091202A1

公开(公告)日：2024-03-21

申请号：US18280329

申请日：2022-03-04

Applicant: Universität Basel

Inventor： Christoph HESS ,  Bojana MÜLLER-DUROVIC ,  Glenn BANTUG

IPC: A61K31/4245 ,  A61K31/47 ,  A61P31/22 ,  C07K16/40 ,  C12N15/113 ,  C12Q1/6874 ,  C12Q1/70

CPC classification number: A61K31/4245 ,  A61K31/47 ,  A61P31/22 ,  C07K16/40 ,  C12N15/1137 ,  C12Q1/6874 ,  C12Q1/701 ,  C12N2310/14 ,  C12N2320/31 ,  C12Q2600/106

Abstract: The invention relates to the treatment and prevention of diseases and conditions associated with EBV infection. In particular, the invention is directed to the use of an IDO1 inhibitor for the treatment and prevention of diseases and conditions associated with EBV infection. The invention also relates to methods for predicting the risk of developing a disease or condition associated with EBV infection.